Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes

被引：63
|
作者：
Jinnouchi, Y.
Yamagishi, S.
Takeuchi, M.
Ishida, S.
Jinnouchi, Y.
Jinnouchi, J.
Imaizumi, T.
机构：
[1] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 8300011, Japan
[2] Hokuriku Univ, Dept Pathophysiol Sci, Kanazawa, Ishikawa 92011, Japan
[3] Ishida Clin, Tosu, Saga, Japan
[4] Sasaguri Hosp, Kasuya, Japan
来源：
CLINICAL AND EXPERIMENTAL MEDICINE | 2006年 / 6卷 / 04期
关键词：
AGEs; oxidative stress; diabetes; statin;
D O I：
10.1007/s10238-006-0115-6
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：191 / 193
页数：3
相关论文
共 50 条
  • [1] Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes
    Y. Jinnouchi
    S. Yamagishi
    M. Takeuchi
    S. Ishida
    Y. Jinnouchi
    J. Jinnouchi
    T. Imaizumi
    [J]. Clinical and Experimental Medicine, 2006, 6 : 191 - 193
  • [2] An α-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes
    Miwako Tsunosue
    Naomi Mashiko
    Yhukou Ohta
    Yoshito Matsuo
    Kouichi Ueda
    Masayuki Ninomiya
    Sho-ichi Tanaka
    Masaru Hoshiko
    Yasutsugu Yoshiyama
    Masayoshi Takeuchi
    Shin-ichiro Ueda
    Sho-ichi Yamagishi
    [J]. Clinical and Experimental Medicine, 2010, 10 : 139 - 141
  • [3] An α-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes
    Tsunosue, Miwako
    Mashiko, Naomi
    Ohta, Yhukou
    Matsuo, Yoshito
    Ueda, Kouichi
    Ninomiya, Masayuki
    Tanaka, Sho-ichi
    Hoshiko, Masaru
    Yoshiyama, Yasutsugu
    Takeuchi, Masayoshi
    Ueda, Shin-ichiro
    Yamagishi, Sho-ichi
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 10 (02) : 139 - 141
  • [4] Advanced glycation end products and their receptors in serum of patients with type 2 diabetes
    Diana Indyk
    Agnieszka Bronowicka-Szydełko
    Andrzej Gamian
    Aleksandra Kuzan
    [J]. Scientific Reports, 11
  • [5] Advanced glycation end products and their receptors in serum of patients with type 2 diabetes
    Indyk, Diana
    Bronowicka-Szydelko, Agnieszka
    Gamian, Andrzej
    Kuzan, Aleksandra
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Elevated Serum Levels of Advanced Glycation End Products and their Monocyte Receptors in Patients with Type 2 Diabetes
    Su, Xu-dong
    Li, Shou-she
    Tian, Ya-qiang
    Zhang, Zhao-yan
    Zhang, Guang-zhen
    Wang, Le-xin
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2011, 42 (07) : 596 - 601
  • [7] Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes
    Tam, H. L.
    Shiu, S. W. M.
    Wong, Y.
    Chow, W. S.
    Betteridge, D. J.
    Tan, K. C. B.
    [J]. ATHEROSCLEROSIS, 2010, 209 (01) : 173 - 177
  • [8] Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
    K. C. B. Tan
    S. W. M. Shiu
    W. S. Chow
    L. Leng
    R. Bucala
    D. J. Betteridge
    [J]. Diabetologia, 2006, 49 : 2756 - 2762
  • [9] Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
    Tan, K. C. B.
    Shiu, S. W. M.
    Chow, W. S.
    Leng, L.
    Bucala, R.
    Betteridge, D. J.
    [J]. DIABETOLOGIA, 2006, 49 (11) : 2756 - 2762
  • [10] Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease
    Kilhovd, BK
    Berg, TJ
    Birkeland, KI
    Thorsby, P
    Hanssen, KF
    [J]. DIABETES CARE, 1999, 22 (09) : 1543 - 1548
12345